MindWalk (NASDAQ: IPA) sets March 12 call on Q3 FY 2026 results

Rhea-AI Filing Summary

MindWalk Holdings Corp. announced it will report financial results for its third quarter of fiscal year 2026 on March 12, 2026. The company will issue a press release before holding a webcasted earnings conference call at 10:30 AM Eastern Time that includes a management presentation and Q&A.

The live webcast and replay will be accessible through the Events section of MindWalk’s investor relations website. Dial-in numbers are provided for U.S. and Canadian participants, and the company encourages listeners to review its periodic reports and risk factor discussions on SEDAR+ and the SEC’s website.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of March, 2026.

Commission File Number: 001-39530

MindWalk Holdings Corp.

3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit	Description
99.1	Press Release dated March 2, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MINDWALK HOLDINGS CORP.
Date: March 2, 2026
	By:	/s/ Jennifer Bath
	Name:	Jennifer Bath
	Title:	President and Chief Executive Officer

99.1

MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026

The Company to host an earnings conference call via webcast

AUSTIN, Texas – MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced that it will report financial results for the third quarter of fiscal year 2026 and host a conference call on Thursday, March 12, 2026, at 10:30 AM Eastern Time. Financial results will be issued in a press release prior to the call, which will include a management presentation followed by a question-and-answer session.

Conference Call and Webcast Details

The live webcast will take place on Thursday, March 12, 2026, at 10:30AM ET. 

The conference call will be webcast live and available for replay via a link provided in the Events section of the Company’s IR pages at:

https://ir.mindwalkai.com/events-and-presentations/default.aspx

* Webcast Details *

Event Title: MindWalk Holdings Corp. – Third Quarter Fiscal Year 2026 Financial Results

Event Date: March 12, 2026, 10:30 AM (GMT-04:00) Eastern Time (US and Canada)

Attendee URL: https://events.q4inc.com/attendee/486881652

Participant Dial-in:

USA / International Toll +1 (646) 307-1963

USA - Toll-Free (800) 715-9871

Canada - Toronto (647) 932-3411

Canada - Toll-Free (800) 715-9871

Conference ID: 3224490

Anyone listening to the call is encouraged to read the company’s periodic reports available on the company’s profile at www.sedarplus.ca and www.sec.gov, including the discussion of risk factors and historical results of operations and financial condition in those reports.

About MindWalk

MindWalk is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT® technology and the LensAI™ platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Investor Contact

Louie Toma, CPA, CFA

Managing Director, CoreIR

investors@mindwalkAI.com

Source: MindWalk Holdings Corp.

FAQ

When will MindWalk (IPA) report third quarter fiscal 2026 results?

MindWalk will report third quarter fiscal year 2026 financial results on March 12, 2026. Results will first be released in a press release, followed by a webcasted conference call including a management presentation and a question-and-answer session for participants.

What time is MindWalk (IPA)’s Q3 FY 2026 earnings conference call?

The third quarter fiscal 2026 earnings conference call is scheduled for 10:30 AM Eastern Time on March 12, 2026. The event includes a management presentation and Q&A, with access available via webcast and telephone dial-in numbers for U.S. and Canadian participants.

How can investors access MindWalk (IPA)’s March 12, 2026 webcast?

Investors can access the March 12, 2026 webcast through the Events section of MindWalk’s investor relations website. A live webcast and replay link will be available, allowing participants to listen to the financial results presentation and subsequent question-and-answer session online.

What are the dial-in numbers for MindWalk (IPA)’s Q3 FY 2026 call?

Participants can dial +1 (646) 307-1963 for U.S. and international access or (800) 715-9871 toll-free in the U.S. and Canada. A Toronto line at (647) 932-3411 and conference ID 3224490 are also provided for the March 12, 2026 earnings call.

What type of company is MindWalk (IPA)?

MindWalk is a Bio-Native AI therapeutic research and technology company focused on transforming drug discovery and development. Its HYFT technology and LensAI platform integrate sequence, structure, function, and literature with a full-stack wet lab to accelerate epitope mapping, molecular design, and biologics analytics.

Where can investors find MindWalk (IPA)’s risk factors and historical results?

Investors are encouraged to review MindWalk’s periodic reports, including risk factors and historical operating results, on its profiles at SEDAR+ (www.sedarplus.ca) and the U.S. SEC website (www.sec.gov). These reports provide important context alongside the upcoming third quarter fiscal 2026 results.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EX-99.1 19.0 KB